{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:23:15Z","timestamp":1793816595638,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690263"],"award-info":[{"award-number":["81690263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biomaterials.2025.123350","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:21:33Z","timestamp":1744870893000},"page":"123350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Improved immunocompatibility of active targeting liposomes by attenuating nucleophilic attack of cyclic RGD peptides on complement 3"],"prefix":"10.1016","volume":"321","author":[{"given":"Nana","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8003-2675","authenticated-orcid":false,"given":"Weiyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.biomaterials.2025.123350_bib1","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1021\/acs.chemrev.5b00116","article-title":"Clinical translation of nanomedicine","volume":"115","author":"Min","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2025.123350_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123350_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114177","article-title":"Tumor-activated carrier-free prodrug nanoparticles for targeted cancer immunotherapy: preclinical evidence for safe and effective drug delivery","volume":"183","author":"Kyu Shim","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123350_bib4","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Accounts Chem. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123350_bib5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/14686996.2019.1625721","article-title":"A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity","volume":"20","author":"Ekdahl","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123350_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule Corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123350_bib7","article-title":"Particle targeting in complex biological media","volume":"7","author":"Dai","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123350_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nnano.2016.269","article-title":"Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange","volume":"12","author":"Chen","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123350_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.semcancer.2019.08.030","article-title":"Targeting integrins for cancer management using nanotherapeutic approaches: recent advances and challenges","volume":"69","author":"Ahmad","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biomaterials.2025.123350_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addr.2017.05.008","article-title":"Modulating angiogenesis with integrin-targeted nanomedicines","volume":"119","author":"Duro-Castano","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123350_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2022.02.030","article-title":"cRGD enables rapid phagocytosis of liposomal vancomycin for intracellular bacterial clearance","volume":"344","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123350_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/adhm.201200006","article-title":"A novel solid lipid nanoparticle formulation for active targeting to tumor alpha(v) beta(3) integrin receptors reveals cyclic RGD as a double-edged sword","volume":"1","author":"Shuhendler","year":"2012","journal-title":"Adv. Healthc. Mater."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123350_bib13","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1021\/acsnano.9b08693","article-title":"Tumor targeting by \u03b1v\u03b23-Integrin-Specific lipid nanoparticles occurs via phagocyte hitchhiking","volume":"14","author":"Sofias","year":"2020","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123350_bib14","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/acs.molpharmaceut.0c00394","article-title":"Factors influencing the immunogenicity and immunotoxicity of cyclic RGD peptide-modified nanodrug delivery systems","volume":"17","author":"Wang","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2025.123350_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2018.12.003","article-title":"Liposomes with cyclic RGD peptide motif triggers acute immune response in mice","volume":"293","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"issue":"27","key":"10.1016\/j.biomaterials.2025.123350_bib16","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1016\/j.biomaterials.2011.05.027","article-title":"The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123350_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.04.012","article-title":"Complement activation by drug carriers and particulate pharmaceuticals: principles, challenges and opportunities","volume":"157","author":"Moghimi","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123350_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08982100802309552","article-title":"Liposome-mediated triggering of complement cascade","volume":"18","author":"Moghimi","year":"2008","journal-title":"J. Liposome Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123350_bib19","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1021\/acsnano.9b07218","article-title":"Premature drug release from polyethylene glycol (PEG)-coated liposomal doxorubicin formation of the membrane attack complex","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123350_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123350_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123350_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123350_bib23","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-018-05384-1","article-title":"Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption","volume":"9","author":"Guan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123350_bib24","article-title":"Measuring the 50% haemolytic complement (CH50) activity of serum","volume":"37","author":"Costabile","year":"2010","journal-title":"J. Vis. Exp."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123350_bib25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41565-023-01514-z","article-title":"Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins","volume":"19","author":"Li","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123350_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/imr.13165","article-title":"Physiology and pathology of the C3 amplification cycle: a retrospective","volume":"313","author":"Peters","year":"2023","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123350_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3-The \"Swiss Army Knife\" of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123350_bib28","article-title":"Combating complement's deleterious effects on nanomedicine by conjugating complement regulatory proteins to nanoparticles","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.biomaterials.2025.123350_bib29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123350_bib30","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1182\/blood-2003-06-2031","article-title":"Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents","volume":"103","author":"Cragg","year":"2004","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.biomaterials.2025.123350_bib31","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.108.832972","article-title":"Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm","volume":"119","author":"Pagano","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123350_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ajh.26410","article-title":"Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice","volume":"97","author":"Deng","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"2\u20133","key":"10.1016\/j.biomaterials.2025.123350_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.molimm.2004.03.011","article-title":"Recombinant cobra venom factor","volume":"41","author":"Vogel","year":"2004","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123350_bib34","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.toxicon.2010.04.007","article-title":"Cobra venom factor: structure, function, and humanization for therapeutic complement depletion","volume":"56","author":"Vogel","year":"2010","journal-title":"Toxicon"},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123350_bib35","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated liposomal doxorubicin (doxil): possible role in hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann. Oncol."},{"issue":"5565","key":"10.1016\/j.biomaterials.2025.123350_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1126\/science.1069040","article-title":"Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an arg-gly-asp ligand","volume":"296","author":"Xiong","year":"2002","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123350_bib37","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.str.2004.09.009","article-title":"Structural insights into how the MIDAS ion stabilizes integrin binding to an RGD peptide under force","volume":"12","author":"Craig","year":"2004","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123350_bib38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens","volume":"124","author":"Helmy","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2025.123350_bib39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123350_bib40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","article-title":"Mechanism of hard-nanomaterial clearance by the liver","volume":"15","author":"Tsoi","year":"2016","journal-title":"Nat. Mater."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225002698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225002698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:31:33Z","timestamp":1777782693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225002698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S0142961225002698"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123350","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved immunocompatibility of active targeting liposomes by attenuating nucleophilic attack of cyclic RGD peptides on complement 3","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123350"}}